🧪 CJC-1295 + Ipamorelin (Research Peptide Blend)
This research formulation combines CJC-1295, a synthetic analog of growth hormone–releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue (GHS). Together, they are studied for their potential synergistic effects on stimulating growth hormone release in laboratory settings.
Key Research Notes:
🔬 CJC-1295 – A GHRH analog designed to stimulate the pituitary gland to release growth hormone. Often modified with DAC (Drug Affinity Complex) for extended half-life.
⚡ Ipamorelin (IPA) – A pentapeptide and selective GHS that mimics ghrelin activity, binding to ghrelin receptors to trigger growth hormone secretion.
🧪 Synergistic Action – When studied together, CJC-1295 and Ipamorelin may produce complementary effects, leading to a more robust and sustained growth hormone release than when researched individually.
📚 Research Applications – Used in experimental models exploring endocrine regulation, metabolism, cellular repair, and growth hormone signaling pathways.
Form: Typically supplied as a lyophilized peptide blend for laboratory and research use.
Disclaimer:This compound blend is provided for laboratory research purposes only. It is not approved for human consumption, medical treatment, or dietary supplementation. No therapeutic or performance claims are made.
